Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Senate approves sweeping opioid bill

The Senate approved a major bill to tackle the opioid crisis with a nearly unanimous vote.

Thumbnail

Coca-Cola considers putting cannabis in a health drink

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.

New CVS Health policy will exclude drugs above cost-effectiveness threshold

CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

Thumbnail

$69B CVS-Aetna deal may get regulatory approval soon

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.

Thumbnail

$67B Cigna-Express Scripts deal clears DOJ

The U.S. Department of Justice (DOJ) Antitrust Division has cleared the $67 billion acquisition of Express Scripts by Cigna.

CMS proposes cutting more regulations

As part of its Patients Over Paperwork initiative, CMS has proposed another round of “red tape” cuts for healthcare providers that could reduce some burdens and loosen regulations across healthcare settings.

Thumbnail

Jefferson and Einstein Healthcare Network reach definitive merger agreement

Jefferson Health and Einstein Healthcare Network have reached a definitive agreement to merge after previously announcing their intentions in March.

Thumbnail

Dartmouth finds article is plagiarized, but NEJM refuses to retract it

The New England Journal of Medicine continues to refuse to retract an article after its lead author was accused of plagiarism and resigned amid an internal investigation, according to STAT. On Sept. 13, H. Gilbert Welch, MD, MPH, stepped down as a professor with the Dartmouth Institute in Lebanon, New Hampshire, after the university found he plagiarized two colleagues in a paper published in NEJM in 2016.

Displaying 1441 - 1448 of 3379

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”